Skip to main content

Year: 2023

Insight Acquisition Corp. Announces Confidential Submission of Form S-4 Registration Statement in Connection with Proposed Business Combination

NEW YORK, Dec. 07, 2023 (GLOBE NEWSWIRE) — Insight Acquisition Corp. (“Insight” or “IAC”) (NASDAQ: INAQ), a publicly traded special purpose acquisition company, today announced the confidential submission with the U.S. Securities and Exchange Commission (“SEC”) of a draft registration statement on Form S-4 (the “Registration Statement”) in connection with the proposed business combination with Alpha Modus, Corp. based in Metro-Charlotte, NC (the “Business Combination”). About Alpha Modus Through its aggregate ‘571 patent holdings, Alpha Modus engages in creating, developing and licensing data-driven technologies to enhance consumers’ in-store digital experience at the point of decision. The company was founded in 2014 and is headquartered in Cornelius, North Carolina. For additional information, please visit alphamodus.com. About...

Continue reading

CooperCompanies Announces Fourth Quarter and Full Year 2023 Results

SAN RAMON, Calif., Dec. 07, 2023 (GLOBE NEWSWIRE) — CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal fourth quarter and full year ended October 31, 2023.Fourth quarter 2023 revenue of $927.1 million, up 9%, and up 9% organically. Fiscal year 2023 revenue of $3.6 billion, up 9%, or up 10% organically. Fourth quarter 2023 GAAP diluted earnings per share (EPS) of $1.70, up 29%. Fiscal 2023 GAAP diluted EPS of $5.91, down 24%. Fourth quarter 2023 non-GAAP diluted EPS of $3.47, up 26%. Fiscal 2023 non-GAAP diluted EPS of $12.81, up 3%. See “Reconciliation of Selected GAAP Results to Non-GAAP Results” below.Commenting on the results, Al White, Cooper’s President and CEO, said, “Fiscal 2023 was another year of record annual revenue driven...

Continue reading

CubeSmart Announces 4.1% Increase in Quarterly Common Dividend

MALVERN, Pa., Dec. 07, 2023 (GLOBE NEWSWIRE) — CubeSmart (NYSE: CUBE) announced today that its Board of Trustees declared a quarterly dividend of $0.51 per common share for the period ending December 31, 2023. The dividend is payable on January 16, 2024 to common shareholders of record on January 2, 2024. The quarterly distribution represents an annualized dividend rate of $2.04 per share, an increase of $0.08 per share from the previous annual rate of $1.96 per share. “We are proud to announce the 14th consecutive annual increase to our dividend,” commented President and Chief Executive Officer Christopher P. Marr. “Our team continues to execute on our growth strategy, and we remain committed to sharing in that growth with our shareholders.” About the Company CubeSmart is a self-administered and self-managed real estate investment...

Continue reading

Genasys Inc. Reports Fiscal Fourth Quarter and Fiscal Year 2023 Financial Results

Genasys Protect Software Gaining Momentum SAN DIEGO, Dec. 07, 2023 (GLOBE NEWSWIRE) — Genasys Inc. (NASDAQ: GNSS), the leader in Protective Communications, today announced financial results for the Company’s fiscal fourth quarter and full year ended September 30, 2023. Richard S. Danforth, Chief Executive Officer of Genasys, Inc., commented, “As we announced in mid- September, our pipeline of hardware and software business continues to grow rapidly. This week’s announcements include some of the business that we had expected in the September quarter. We expect that we will book each of the forecasted hardware orders that shifted out of our fiscal 2023. In the fourth quarter of fiscal 2023, recurring revenues in our software business were up 43% year over year and 21% sequentially. Based on current contracting activity, the addition...

Continue reading

Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2023

— Recorded Second Quarter Revenue of $25.4 Million — — Signed $35 Million in Net New Business Orders Resulting in a Backlog of $199 Million — — Entered into Partnership with California Institute of Regenerative Medicine (CIRM) to Advance Manufacturing of Adeno-Associated Adenovirus, as well as Other Cell and Gene Therapy Programs – — Completed Construction of Cell and Gene Therapy Facility; Grand Opening Scheduled for January 2024 — — Adjusting Fiscal 2024 Revenue Guidance to $137 to $147 million — TUSTIN, Calif., Dec. 07, 2023 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology...

Continue reading

AAR to announce second quarter fiscal year 2024 results on December 21, 2023

Wood Dale, Illinois, Dec. 07, 2023 (GLOBE NEWSWIRE) — AAR CORP. (NYSE: AIR), a leading provider of aviation services to commercial and government operators, MROs, and OEMs, today announced that it will release financial results for its second quarter of fiscal year 2024, ended November 30, 2023, after the close of the New York Stock Exchange trading session on Thursday, December 21, 2023. On Thursday, December 21, 2023, at 3:45 p.m. Central time, AAR will hold a conference call to discuss the results. The conference call can be accessed by registering at https://register.vevent.com/register/BIe408558c6b344fb2aca2a3d5d43d47f9. Once registered, participants will receive a dial-in number and a unique PIN that will allow them to access the call. A replay of the conference call will be available for on-demand listening shortly after...

Continue reading

HashiCorp Announces Third Quarter of Fiscal Year 2024 Financial Results

Third quarter revenue totaled $146.1 million, representing an increase of 17% year-over-year. Trailing four quarter average Net Dollar Retention Rate was 119% at the end of the third quarter of fiscal 2024 as compared to 134% at the end of third quarter of fiscal 2023. Third quarter total GAAP RPO totaled $678.2 million, representing an increase of 28% year-over-year; Third quarter current GAAP RPO totaled $402.1 million, representing an increase of 25% year-over-year. Third quarter total non-GAAP RPO totaled $700.4 million, representing an increase of 27% year-over-year; Third quarter current non-GAAP RPO totaled $420.8 million, representing an increase of 23% year-over-year. Third quarter GAAP net loss totaled $39.5 million. The third quarter was HashiCorp’s first quarter with positive Non-GAAP net income, which totaled $5.6 million.SAN...

Continue reading

Dynagas LNG Partners LP Reports Results For the Three and Nine Months Ended September 30, 2023

ATHENS, Greece, Dec. 07, 2023 (GLOBE NEWSWIRE) — Dynagas LNG Partners LP (NYSE: “DLNG”) (“the “Partnership”), an owner and operator of liquefied natural gas (“LNG”) carriers, today announced its results for the three and nine months ended September 30, 2023. Nine months Highlights:Net Income and Earnings per common unit (basic and diluted) of $25.4 million and $0.45, respectively; Adjusted Net Income(1) of $15.5 million and Adjusted Earnings per common unit (1) (basic and diluted) of $0.18; Adjusted EBITDA(1) $67.0 million; and 97% fleet utilization(2).Quarter Highlights:Net Income of $1.4 million and Loss per common unit (basic and diluted) of $0.04; Adjusted Net Income(1) of $3.1 million and Adjusted Earnings(1) per common unit (basic and diluted) of $0.01; Adjusted EBITDA(1) $20.4 million; 99.8% fleet utilization(2); Declared...

Continue reading

Major Drilling Achieves Highest Revenue in More Than Ten Years; Strong Cash Generation Drives Share Repurchases

MONCTON, New Brunswick, Dec. 07, 2023 (GLOBE NEWSWIRE) — Major Drilling Group International Inc. (“Major Drilling” or the “Company”) (TSX: MDI), a leading provider of specialized drilling services to the mining sector, today reported results for the second quarter of fiscal 2024, ended October 31, 2023. Quarterly HighlightsRevenue of $207.0 million, highest revenue since July 2012. EBITDA(1) of $43.6 million (or $0.53 per share), up from $43.0 million (or $0.52 per share) for the same period last year. Net earnings of $23.7 million (or $0.29 per share), up from $23.6 million (or $0.29 per share) for the same period last year. Spent $7.3 million repurchasing 875,268 shares. Net cash(1) position increased $23.4 million during the quarter to $84.2 million.“We continued to see strength in our business as the increase in demand...

Continue reading

Study Estimates a 23% Increase in COPD by 2050, Representing 600 Million Patients Globally

Published in the Journal of the American Medical Association Network Open, study estimates global COPD burden from 2020 through 2050 Study projects disproportionate growth in COPD among women and low-middle income regionsSAN DIEGO, Dec. 07, 2023 (GLOBE NEWSWIRE) — ResMed (NYSE: RMD, ASX: RMD) today announced the results of a study on the global burden of Chronic Obstructive Pulmonary Disease (COPD) through 2050. Published in the Journal of the American Medical Association (JAMA) Network Open, the study found that COPD prevalence among those 25 years and older is expected to increase by 23% from 2020 to 2050, with the largest growth projected among women and within low- and middle-income countries. According to the World Health Organization, COPD is the third deadliest disease in the world. Today, there are an estimated 480...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.